Feng Mao Hua
Director/Board Member at LEPU BIOPHARMA CO., LTD.
Feng Mao Hua active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SIRNAOMICS LTD. | Director/Board Member | 2021-11-30 | - |
| Independent Dir/Board Member | 2021-11-30 | - | |
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Director/Board Member | 2021-06-30 | - |
| Independent Dir/Board Member | 2021-06-30 | - | |
| LEPU BIOPHARMA CO., LTD. | Director/Board Member | 2021-11-30 | - |
| Independent Dir/Board Member | 2021-11-30 | - | |
Shanghai NewMed Medical Co., Ltd.
 Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Director/Board Member | 2021-07-20 | - |
| Independent Dir/Board Member | 2021-07-20 | - | |
| China Finance Strategies Investment Holdings Ltd. | Chairman | 2014-07-31 | - |
BioSyngen Pte Ltd.
 BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Chairman | - | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - |
Career history of Feng Mao Hua
Former positions of Feng Mao Hua
| Companies | Position | Start | End |
|---|---|---|---|
| FERRETTI S.P.A. | Director/Board Member | 2021-12-20 | 2024-02-18 |
| Independent Dir/Board Member | 2021-12-20 | 2024-02-18 | |
| VIVA BIOTECH HOLDINGS | Director/Board Member | 2018-06-30 | 2021-06-29 |
| Director of Finance/CFO | 2018-06-30 | 2021-04-28 | |
| Founder | 2008-08-26 | 2021-06-29 | |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░ ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Feng Mao Hua
| International University of Japan | Masters Business Admin |
| Shanghai International Studies University | Undergraduate Degree |
Statistics
International
| China | 11 |
| Hong Kong | 10 |
| Italy | 2 |
Operational
| Director/Board Member | 11 |
| Independent Dir/Board Member | 8 |
| Corporate Officer/Principal | 5 |
Sectoral
| Health Technology | 9 |
| Finance | 7 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 8 |
|---|---|
| AGTECH HOLDINGS LIMITED | Distribution Services |
| FERRETTI S.P.A. | Consumer Durables |
| CHEMPARTNER PHARMATECH CO.,LTD. | Commercial Services |
| BOCOM INTERNATIONAL HOLDINGS COMPANY LIMITED | Finance |
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Commercial Services |
| VIVA BIOTECH HOLDINGS | Health Technology |
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Private companies | 13 |
|---|---|
CLSA Ltd.
 CLSA Ltd. Investment ManagersFinance CLSA Ltd. is the Hong Kong-based institutional brokerage subsidiary of CITIC Securities Co., Ltd. (SSE: 600030, SEHK: 6030), a full-service investment bank headquartered in China. Founded in 1986, the firm provides sales and execution services to global investors and corporates. | Finance |
| Cazenove Asia Ltd. | Finance |
CLSA Equity Capital Markets Ltd.
 CLSA Equity Capital Markets Ltd. Investment Banks/BrokersFinance Part of CITIC Securities Co., Ltd., CLSA Equity Capital Markets Ltd. provides investment management services. The private company is based in Hong Kong, Hong Kong. | Finance |
ICEA Capital Ltd.
 ICEA Capital Ltd. Regional BanksFinance Part of Industrial & Commercial Bank of China Ltd., ICEA Capital Ltd. provides banking services. The private company is based in Hong Kong, Hong Kong. | Finance |
Bank of America, NA (Charlotte, North Carolina)
 Bank of America, NA (Charlotte, North Carolina) Major BanksFinance Bank of America, NA engages in the provision of commercial banking services. It offers financing, checking and savings accounts, and investment banking for individual clients. The company was founded on March 1, 1927 and is headquartered in Charlotte, NC. | Finance |
| China Finance Strategies Ltd. | |
Zhejiang Langhua Pharmaceutical Co., Ltd.
 Zhejiang Langhua Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Langhua Pharmaceutical Co., Ltd. engages in the production and manufacture of active pharmaceutical ingredient and intermediate products. Its products include ciprofloxacin hydrochloride, enrofloxacin, levofloxacin hemihydrate, levofloxacin hydrochloride, spironolactone, zidovudine, canrenone, and ciprofloxacin q-acid. The company was founded in 1986 and is headquartered in Taizhou, China. | Health Technology |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Health Technology |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Health Technology |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |
Hebei Titans Medical Supply Technology Group Co. Ltd.
 Hebei Titans Medical Supply Technology Group Co. Ltd. Medical SpecialtiesHealth Technology Hebei Titans Medical Supply Technology Group Co. Ltd. engages in the manufacture of personal hand protection products. Its products are disposable nitrile gloves and disposable vinyl gloves, which are widely used in medical care, clinical examination, chemical industry, electronics, food processing and other industries. The company was founded by Wen Xin Lu and Wei Dong Liu on February 23, 2011 and is headquartered in Xingtai, China. | Health Technology |
| Cfs Global Resources Co. Ltd. | |
| China Finance Strategies Investment Holdings Ltd. |
- Stock Market
- Insiders
- Feng Mao Hua
- Experience